Clinical Trials Browser

Phase 2 × Interventional × PVX-410 vaccine × Clear all

NCT04634747 2022-04-20

Phase 2 Study to Evaluate PVX-410 + Pembrolizumab + Chemotherapy for Metastatic, PD-L1+ Triple-Negative Breast Cancer

Phase 2 Unknown

Triple Negative Breast Neoplasms